HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
RVP
Retractable Technologies, Inc.
There isn't enough reported data to score RVP yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
RVP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
RVP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
RVP PE Valuation
RVP has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
RVP Forward outlook
There aren't enough analyst estimates for RVP to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
RVP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.15 |
| Q1 2026 | -$0.22 | +$0.54 |
| Q4 2025 | -$0.43 | -$0.03 |
| Q3 2025 | -$0.20 | +$0.34 |
| Q2 2025 | -$0.28 | +$0.33 |
| Q1 2025 | -$0.76 | -$0.50 |
| Q4 2024 | -$0.40 | -$0.16 |
| Q3 2024 | -$0.54 | -$0.17 |
RVP is still losing money, but far less than before: $0.13 per share over the past year, against $0.76 at its worst in early 2025.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over RVP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over RVP on profitability, with a higher operating margin.
RVP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.2M | -31% |
| Q1 2026 | $7.2M | -13% |
| Q4 2025 | $9.4M | +4% |
| Q3 2025 | $10.1M | -2.5% |
| Q2 2025 | $10.4M | +73% |
| Q1 2025 | $8.3M | +9.2% |
| Q4 2024 | $9.1M | -36% |
| Q3 2024 | $10.3M | +0.1% |
RVP's revenue has slid since its 2021 peak: $7M last quarter, down 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -71% | -22 points |
| Q1 2026 | -86% | -30 points |
| Q4 2025 | -82% | -2.1 points |
| Q3 2025 | -36% | +13 points |
| Q2 2025 | -49% | +47 points |
| Q1 2025 | -56% | -17 points |
| Q4 2024 | -80% | -60 points |
| Q3 2024 | -50% | -41 points |
RVP's operating margin was โ71% last quarter, down 22 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over RVP on cash generation, producing positive trailing cash flow while its opponent burns cash.
RVP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | +$2.3M |
| Q1 2026 | -$1.4M | +$187.9K |
| Q4 2025 | -$596.5K | +$806.3K |
| Q3 2025 | -$1.3M | +$5.2M |
| Q2 2025 | -$4.1M | -$1.2M |
| Q1 2025 | -$1.6M | +$686.6K |
| Q4 2024 | -$1.4M | -181% |
| Q3 2024 | -$6.5M | -185% |
RVP has burned cash in most quarters: โ$5M over the past year, against โ$14M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
RVP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -4.8x | Net Cash |
| Q3 2022 | -0.3x | Net Cash |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.7x | Net Cash |
| Q4 2021 | -0.4x | Net Cash |
| Q3 2021 | -0.3x | Net Cash |
| Q2 2021 | -0.3x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
RVP has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
RVP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 1.7 | Oversold |
RVP's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
RVP PE vs Healthcare Sector
| Metric | RVP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
RVP has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
RVP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.61 | 8.2% below |
| 20 week MA | $0.66 | 15% below |
| 50 week MA | $0.69 | 19% below |
| 100 week MA | $0.73 | 23% below |
| 200 week MA | $0.96 | 42% below |
RVP is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to โ56% in 2021. It's down 42% so far in 2026.
RVP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.47 | $11.3 | +669% |
| 2021 | $11.3 | $6.98 | -38% |
| 2022 | $6.98 | $1.74 | -75% |
| 2023 | $1.74 | $1.11 | -36% |
| 2024 | $1.11 | $0.68 | -39% |
| 2025 | $0.68 | $0.83 | +22% |
| 2026 YTD | $0.83 | $0.56 | -33% |
RVP has the edge over HIMS on returns for 2026, with the stronger performance.